Phaos Technology Holdings (Cayman) (POAS) Inventory Average (2025)
Phaos Technology Holdings (Cayman) (POAS) posted Inventory Average of $271786.1 for Q4 2025, up 46.44% on a QoQ basis from $185597.5 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Inventory Average (2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Inventory Average history runs 1 years deep, the most recent figure standing at $271786.1 for Q4 2025.
- Quarterly Inventory Average changed N/A year-over-year to $271786.1 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $271786.1 (changed N/A YoY) and the FY2025 annual result came in at $185703.7, changed N/A from the prior year.
- Inventory Average was $271786.1 for Q4 2025 at Phaos Technology Holdings (Cayman), up from $185597.5 in the prior quarter.
- Across five years, Inventory Average topped out at $271786.1 in Q4 2025 and bottomed at $185597.5 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 1.12 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 661.35 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | 2.29 Bn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 3.49 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.44 Mn | 6.38 Mn | - | 271,786.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 271,786.11 |
| Apr 30, 2025 | 185,597.51 |